JP2002098687A - Inspection agent for dermatropic pathogen - Google Patents
Inspection agent for dermatropic pathogenInfo
- Publication number
- JP2002098687A JP2002098687A JP2001058735A JP2001058735A JP2002098687A JP 2002098687 A JP2002098687 A JP 2002098687A JP 2001058735 A JP2001058735 A JP 2001058735A JP 2001058735 A JP2001058735 A JP 2001058735A JP 2002098687 A JP2002098687 A JP 2002098687A
- Authority
- JP
- Japan
- Prior art keywords
- water
- soluble polymer
- inspection
- skin
- macromolecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000007689 inspection Methods 0.000 title claims abstract description 56
- 244000052769 pathogen Species 0.000 title claims abstract description 21
- 230000001717 pathogenic effect Effects 0.000 title abstract description 7
- 239000000463 material Substances 0.000 claims description 95
- 229920003169 water-soluble polymer Polymers 0.000 claims description 54
- 238000012360 testing method Methods 0.000 claims description 46
- 239000000758 substrate Substances 0.000 claims description 21
- 239000000853 adhesive Substances 0.000 claims description 19
- 230000001070 adhesive effect Effects 0.000 claims description 19
- 230000003071 parasitic effect Effects 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 12
- 238000010030 laminating Methods 0.000 claims description 4
- 230000035699 permeability Effects 0.000 claims description 4
- -1 poly(vinyl acetate) Polymers 0.000 abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 19
- 239000002904 solvent Substances 0.000 abstract description 14
- 239000011148 porous material Substances 0.000 abstract description 13
- 239000003795 chemical substances by application Substances 0.000 abstract description 10
- 229920001577 copolymer Polymers 0.000 abstract description 8
- 239000000945 filler Substances 0.000 abstract description 7
- 239000004014 plasticizer Substances 0.000 abstract description 7
- 239000004094 surface-active agent Substances 0.000 abstract description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 239000011118 polyvinyl acetate Substances 0.000 abstract description 3
- 229920002689 polyvinyl acetate Polymers 0.000 abstract description 3
- 239000003755 preservative agent Substances 0.000 abstract description 3
- 229920000310 Alpha glucan Polymers 0.000 abstract description 2
- 229920002498 Beta-glucan Polymers 0.000 abstract description 2
- 102000008186 Collagen Human genes 0.000 abstract description 2
- 108010035532 Collagen Proteins 0.000 abstract description 2
- 229920002488 Hemicellulose Polymers 0.000 abstract description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 abstract description 2
- 241000509427 Sarcoptes scabiei Species 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 229920001436 collagen Polymers 0.000 abstract description 2
- 125000000524 functional group Chemical group 0.000 abstract description 2
- 229920001519 homopolymer Polymers 0.000 abstract description 2
- 239000001814 pectin Substances 0.000 abstract description 2
- 235000010987 pectin Nutrition 0.000 abstract description 2
- 229920001277 pectin Polymers 0.000 abstract description 2
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 abstract description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract description 2
- 230000002335 preservative effect Effects 0.000 abstract description 2
- 229920002521 macromolecule Polymers 0.000 abstract 6
- 239000000306 component Substances 0.000 abstract 1
- 239000000413 hydrolysate Substances 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000003507 refrigerant Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 49
- 210000003491 skin Anatomy 0.000 description 47
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 206010063409 Acarodermatitis Diseases 0.000 description 13
- 241000447727 Scabies Species 0.000 description 13
- 208000005687 scabies Diseases 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 239000000123 paper Substances 0.000 description 12
- 241000238631 Hexapoda Species 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 239000000835 fiber Substances 0.000 description 7
- 238000009940 knitting Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229920000139 polyethylene terephthalate Polymers 0.000 description 7
- 239000005020 polyethylene terephthalate Substances 0.000 description 7
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 239000004745 nonwoven fabric Substances 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 241000238876 Acari Species 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001674048 Phthiraptera Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000258242 Siphonaptera Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229920002050 silicone resin Polymers 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000003522 acrylic cement Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 239000006229 carbon black Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 210000001113 umbilicus Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000002759 woven fabric Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000233788 Arecaceae Species 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- IDCBOTIENDVCBQ-UHFFFAOYSA-N TEPP Chemical compound CCOP(=O)(OCC)OP(=O)(OCC)OCC IDCBOTIENDVCBQ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920002978 Vinylon Polymers 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012615 aggregate Substances 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 210000001099 axilla Anatomy 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000009683 detection of insect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- JLYXXMFPNIAWKQ-GNIYUCBRSA-N gamma-hexachlorocyclohexane Chemical compound Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl JLYXXMFPNIAWKQ-GNIYUCBRSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011086 glassine Substances 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940105082 medicinal charcoal Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003207 poly(ethylene-2,6-naphthalate) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920006289 polycarbonate film Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011112 polyethylene naphthalate Substances 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920002620 polyvinyl fluoride Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229920005992 thermoplastic resin Polymers 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- FZGFBJMPSHGTRQ-UHFFFAOYSA-M trimethyl(2-prop-2-enoyloxyethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCOC(=O)C=C FZGFBJMPSHGTRQ-UHFFFAOYSA-M 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、皮膚寄生性病原
体、更に詳しくはダニ、ノミ及びシラミの検査材、検査
材キット及び検査方法に関するものである。The present invention relates to a skin parasitic pathogen, and more particularly to a test material, a test material kit and a test method for mites, fleas and lice.
【0002】[0002]
【従来の技術】ダニ、ノミ及びシラミ等、ヒトの皮膚に
寄生する病原体は多い。その中でも、疥癬はヒト疥癬虫
(Sarcoptes scabiei var hominis:俗称ヒゼンダニ)に
より引き起こされる強い痒みを伴う感染症であり、老人
医療施設を中心に感染が拡大している。ヒト疥癬虫の幼
虫及びオス成虫はヒトの皮膚表面に棲息するが、メス成
虫は角質内に棲息し、疥癬トンネルと呼ばれる穴を掘り
進み、産卵しながら皮膚中を移動する。また、接触感染
により伝染するため、患者間だけでなく医療従事者から
その家族への感染も問題となる。2. Description of the Related Art There are many pathogens, such as mites, fleas and lice, which are parasitic on human skin. Among them, scabies are human scabies
(Sarcoptes scabiei var hominis: common name mite) is an infectious disease accompanied by intense itch, and its infection is expanding mainly in geriatric care facilities. Human scabies larvae and male adults live on the surface of human skin, while female adults live in the stratum corneum, dig through holes called scabies tunnels, and move through the skin while laying eggs. In addition, since the infection is transmitted by contact infection, transmission not only between patients but also from a medical staff to their families becomes a problem.
【0003】外国ではγ−BHC等の農薬を用いた治療
により治療成果を上げているが、日本国内ではその使用
は認められておらず、その治療は困難を極める。そのた
め、感染が疑われた場合、速やかかつ確実に診断し、患
者を早急に隔離することが伝染予防のために最も重要に
なる。[0003] In foreign countries, treatments using pesticides such as γ-BHC have been successful, but in Japan, their use has not been approved, and the treatment is extremely difficult. Therefore, when infection is suspected, prompt and reliable diagnosis and the immediate isolation of patients are of paramount importance in preventing transmission.
【0004】[0004]
【発明が解決しようとする課題】疥癬の確定診断は、虫
体(抜け殻も含む)又は虫卵を確認することにより行わ
れるが、居場所を特定することが難しいオス成虫又は幼
虫に比べ、疥癬トンネル中に潜むメス成虫は比較的容易
に見つけることができる。現在の疥癬の検査方法は疥癬
トンネルを丹念に調べ、トンネルの先端を針でつつき、
採取したサンプルからヒト疥癬虫を顕微鏡にて確認して
いる。しかし、比較的容易ではあるとはいえ、どこにい
るか分からないため、その検出率は約60%と低率であ
る。The definite diagnosis of scabies is made by checking the worm body (including the husks) or eggs, but compared to a male adult or larva whose location is difficult to identify, it is a scabies tunnel. Female adults lurking in them are relatively easy to find. The current scabies inspection method carefully examines the scabies tunnel, pricks the tip of the tunnel with a needle,
Human scabies were observed under a microscope from the collected samples. However, although relatively easy, where it is unknown, the detection rate is as low as about 60%.
【0005】[0005]
【課題を解決するための手段】本発明者らは、皮膚寄生
性病原体の検査材に関して鋭意研究を行った結果、水溶
性高分子を含有する皮膚寄生性病原体の検査材が、毛穴
等を含む皮膚表面に棲息するヒト疥癬虫をはじめとする
皮膚寄生性病原体を確実に捕獲し、検出率を飛躍的に向
上させることを見出し本発明を完成するに至った。Means for Solving the Problems The present inventors have conducted intensive studies on test materials for skin parasitic pathogens. As a result, the test material for skin parasitic pathogens containing water-soluble polymers contains pores and the like. The present inventors have found that skin parasitic pathogens such as human scabies living on the skin surface are reliably captured and the detection rate is dramatically improved, and the present invention has been completed.
【0006】即ち、本発明は以下の発明を包含する。 (1)水溶性高分子を含有する皮膚寄生性病原体の検査
材。 (2)透明性を有する前記(1)に記載の検査材。 (3)シート状である前記(1)又は(2)に記載の検
査材。 (4)シート状であり、基材と、水溶性高分子を含有す
る層とを積層してなる前記(1)に記載の検査材。 (5)基材が通気性及び可撓性を有する前記(4)に記
載の検査材。 (6)ペースト状である前記(1)又は(2)に記載の
検査材。 (7)前記(2)又は(6)に記載の検査材と透明性を
有する粘着シートとを含む皮膚寄生性病原体の検査材キ
ット。 (8)前記(2)又は(6)に記載の検査材を皮膚から
剥離する際に、透明性を有する粘着シートを用いる皮膚
寄生性病原体の検査方法。That is, the present invention includes the following inventions. (1) A test material for skin parasitic pathogens containing a water-soluble polymer. (2) The inspection material according to (1), which has transparency. (3) The inspection material according to (1) or (2), which is in the form of a sheet. (4) The inspection material according to the above (1), which is in the form of a sheet and is formed by laminating a substrate and a layer containing a water-soluble polymer. (5) The inspection material according to (4), wherein the base material has air permeability and flexibility. (6) The inspection material according to (1) or (2), which is in a paste form. (7) A test kit for skin parasitic pathogens, comprising the test material according to (2) or (6) and a transparent adhesive sheet. (8) A method for examining skin parasitic pathogens using a transparent adhesive sheet when the test material according to (2) or (6) is peeled from the skin.
【0007】[0007]
【発明の実施の形態】本発明に用いる水溶性高分子とし
ては、例えば、イオン性官能基(例えば、カルボキシル
基、アミノ基、スルホン酸残基、リン酸残基、硫酸エス
テル基、リン酸エステル基等)を有する単独もしくは共
重合体(例えば、ランダム、ブロック、交互)又はその
塩(例えば、ポリ(メタ)アクリル酸、(メタ)アクリ
ル酸・(メタ)アクリル酸エステル共重合体、ポリ(メ
タ)アクリル酸アルカノールアミン、(メタ)アクリル
酸・スチレン共重合体又はその塩、ポリ塩化(メタ)ア
クリロイルオキシエチルトリメチルアンモニウム、コン
ドロイチン硫酸又はその塩)、ポリビニルアルコール、
ポリビニルピロリドン、酢酸ビニル・ビニルピロリドン
共重合体、ポリエチレンオキシド、ポリビニルメチルエ
ーテル、コラーゲンの加水分解物又はその変性物(例え
ば、ゼラチン)、ペクチン、その他β−1,3−グルカ
ン、α−グルカン、(ヘミ)セルロース類(例えば、ヒ
ドロキシプロピルセルロース)等が挙げられる。DESCRIPTION OF THE PREFERRED EMBODIMENTS The water-soluble polymer used in the present invention includes, for example, ionic functional groups (for example, carboxyl group, amino group, sulfonic acid residue, phosphoric acid residue, sulfate ester group, phosphate ester). Group or the like) (for example, random, block, alternating) or a salt thereof (for example, poly (meth) acrylic acid, (meth) acrylic acid / (meth) acrylate copolymer, poly ( Alkanolamine (meth) acrylate, (meth) acrylic acid / styrene copolymer or a salt thereof, poly (meth) acryloyloxyethyltrimethylammonium chloride, chondroitin sulfate or a salt thereof), polyvinyl alcohol,
Polyvinylpyrrolidone, vinyl acetate / vinylpyrrolidone copolymer, polyethylene oxide, polyvinyl methyl ether, a hydrolyzate of collagen or a modified product thereof (eg, gelatin), pectin, other β-1,3-glucan, α-glucan, Hemi) celluloses (for example, hydroxypropyl cellulose) and the like.
【0008】本発明の検査材は、水溶性を阻害しない範
囲で、ポリ酢酸ビニル、ポリ(メタ)アクリル酸エステ
ル等の非水溶性高分子を含有することができる。本発明
の検査材は、この他に、必要に応じて、可塑剤、油性成
分、界面活性剤、充填剤、保湿剤、溶媒、防腐剤、角質
溶解剤、清涼化剤、薬物、香料、抗酸化剤等を含有する
ことができる。The test material of the present invention can contain a water-insoluble polymer such as polyvinyl acetate and poly (meth) acrylate as long as the water solubility is not impaired. The test material of the present invention may further contain, if necessary, a plasticizer, an oily component, a surfactant, a filler, a humectant, a solvent, a preservative, a keratolytic agent, a refreshing agent, a drug, a fragrance, An oxidizing agent or the like can be contained.
【0009】可塑剤としては、例えば、エチレングリコ
ール、ジエチレングリコール、トリエチレングリコー
ル、それ以上のポリエチレングリコール、プロピレング
リコール、ジプロピレングリコール、トリプロピレング
リコール、それ以上のポリプロピレングリコール、1,
3−ブタンジオール、1,4−ブタンジオール等のブタ
ンジオール、グリセリン、ジグリセリン、トリグリセリ
ン、それ以上のポリグリセリン等の多価アルコール類が
挙げられる。[0009] Examples of the plasticizer include ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, polypropylene glycol, 1, and more.
Examples thereof include polyhydric alcohols such as butanediol such as 3-butanediol and 1,4-butanediol, glycerin, diglycerin, triglycerin, and higher polyglycerin.
【0010】検査材中におけるこれらの可塑剤の含有量
は、水溶性高分子100重量部当り0.01〜100重
量部程度が好ましく、1〜30重量部程度がより好まし
い。可塑剤の含有量が少な過ぎると、前記水溶性高分子
の平均分子量や含有量等によっては、検査材が硬化し、
割れを生じ、取り扱い性が悪くなり、また、可塑剤の含
有量が多過ぎると、前記水溶性高分子の平均分子量や含
有量等によっては、検査材が軟化し、接着力が低下し、
皮膚寄生性病原体の捕獲が不十分となる。[0010] The content of these plasticizers in the test material is preferably about 0.01 to 100 parts by weight, more preferably about 1 to 30 parts by weight, per 100 parts by weight of the water-soluble polymer. If the content of the plasticizer is too small, depending on the average molecular weight and the content of the water-soluble polymer, the test material is cured,
Cracks occur, handling becomes poor, and if the content of the plasticizer is too large, depending on the average molecular weight or the content of the water-soluble polymer, the test material is softened, and the adhesive strength is reduced,
Poor capture of skin parasitic pathogens.
【0011】油性成分としては、例えば、流動パラフィ
ン、スクワラン、ワセリン、固形パラフィン等の炭化水
素、ホホバ油、ヒマシ油、オリーブ油、卵黄油、ヤシ油
等の天然油、ポリジメチルシロキサン等のシリコーン
油、オレイン酸、イソステアリン酸等の高級脂肪酸、ラ
ウリルアルコール等の高級アルコール類、ミリスチン酸
イソプロピル等のエステル類が挙げられる。Examples of the oil component include hydrocarbons such as liquid paraffin, squalane, petrolatum, and solid paraffin; natural oils such as jojoba oil, castor oil, olive oil, egg yolk oil, and coconut oil; silicone oils such as polydimethylsiloxane; Examples include higher fatty acids such as oleic acid and isostearic acid, higher alcohols such as lauryl alcohol, and esters such as isopropyl myristate.
【0012】検査材中におけるこれらの油性成分の含有
量は、水溶性高分子100重量部当り0.01〜100
重量部程度が好ましく、1〜30重量部程度がより好ま
しい。油性成分の含有量が少な過ぎると、検査材の剥離
時の痛みが強くなり、油性成分の含有量が多過ぎると、
皮膜強度が低下し、また表面に滲み出した油性成分によ
りヒト疥癬虫への接着力が低下する。The content of these oily components in the test material is 0.01 to 100 per 100 parts by weight of the water-soluble polymer.
About 1 part by weight is preferable, and about 1 to 30 parts by weight is more preferable. If the content of the oily component is too small, the pain at the time of peeling the test material becomes strong, and if the content of the oily component is too large,
The film strength is reduced, and the adhesion to human scabies is reduced due to the oily component oozing out on the surface.
【0013】界面活性剤としては、例えば、非イオン性
界面活性剤であるグリセリン脂肪酸エステル、ソルビタ
ン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪
酸エステル、ポリオキシエチレンヒマシ油、ポリオキシ
エチレン硬化ヒマシ油、ポリオキシエチレンアルキルエ
ーテル等、陰イオン界面活性剤であるN−アシルアミノ
酸塩等、陽イオン界面活性剤である脂肪族4級アンモニ
ウム塩等、両性界面活性剤であるベタイン類等が挙げら
れる。Examples of the surfactant include nonionic surfactants such as glycerin fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene castor oil, polyoxyethylene hardened castor oil, and polyoxyethylene. Examples thereof include N-acyl amino acid salts which are anionic surfactants such as alkyl ethers, and aliphatic quaternary ammonium salts which are cationic surfactants, and betaines which are amphoteric surfactants.
【0014】検査材中におけるこれらの界面活性剤の含
有量は、水溶性高分子100重量部当り0.01〜10
重量部程度が好ましく、0.05〜5重量部程度がより
好ましい。界面活性剤の含有量が少な過ぎると、前記油
性成分が検査材中に均一に分散されにくくなり、界面活
性剤の含有量が多過ぎると、ヒト疥癬虫への接着力が低
下する。The content of these surfactants in the test material is 0.01 to 10 per 100 parts by weight of the water-soluble polymer.
It is preferably about 5 parts by weight, more preferably about 0.05 to 5 parts by weight. If the content of the surfactant is too small, it is difficult for the oily component to be uniformly dispersed in the test material, and if the content of the surfactant is too large, the adhesive force to human scabies decreases.
【0015】充填剤としては、例えば、タルク、セリサ
イト、炭酸カルシウム、カオリン、無水ケイ酸、含水ケ
イ酸、酸化チタン、マイカチタン、薬用炭、カーボンブ
ラック等の無機充填剤や、ポリアミド、ポリエチレン、
セルロース、ポリメタクリル酸メチル等の粉末(特に球
状粉末)等の有機充填剤、これらを金属石けん、エステ
ル、シリコーン等で疎水処理したものが挙げられる。Examples of the filler include inorganic fillers such as talc, sericite, calcium carbonate, kaolin, silicic acid anhydride, hydrous silicic acid, titanium oxide, mica titanium, medicinal charcoal, carbon black, polyamide, polyethylene,
Organic fillers such as powders (especially spherical powders) of cellulose, polymethyl methacrylate and the like, and those obtained by subjecting these to hydrophobic treatment with metallic soap, ester, silicone, or the like.
【0016】このような充填剤(特に顔料)の検査材中
における含有量は、水溶性高分子100重量部当り15
0重量部以下が好ましく、1〜75重量部程度がより好
ましい。充填剤の含有量が多過ぎると、皮膚寄生性病原
体の捕獲性能が低下する。溶媒としては、水及びエタノ
ール、イソプロパノール等の低級アルコール等並びにこ
れらの混合物が挙げられる。The content of such filler (particularly pigment) in the test material is 15 per 100 parts by weight of the water-soluble polymer.
0 parts by weight or less is preferable, and about 1 to 75 parts by weight is more preferable. If the content of the filler is too large, the performance of capturing the skin parasitic pathogen decreases. Examples of the solvent include water and lower alcohols such as ethanol and isopropanol, and mixtures thereof.
【0017】ペースト状検査材における溶媒含量は、通
常10〜95.5重量%、好ましくは20〜80重量%
であり、シート状検査材の水溶性高分子を含有する層を
構成する組成物における溶媒の含量は、通常30重量%
以下、好ましくは20重量%以下である。防腐剤として
は、例えばパラオキシ安息メチルのようなパラオキシ安
息香酸エステル類、塩化ベンザルコニウム等が挙げられ
る。保湿剤としては、各種アルコール類や糖類が挙げら
れる。The solvent content in the paste-like test material is usually 10 to 95.5% by weight, preferably 20 to 80% by weight.
The content of the solvent in the composition constituting the layer containing the water-soluble polymer of the sheet-like inspection material is usually 30% by weight.
Or less, preferably 20% by weight or less. Examples of preservatives include paraoxybenzoic acid esters such as methyl paraoxybenzoate, and benzalkonium chloride. Examples of the humectant include various alcohols and sugars.
【0018】角質溶解剤としては、例えば乳酸、パパイ
ン、ビオブラーゼ、サリチル酸、グリコール酸、クエン
酸、リンゴ酸が挙げられる。清涼化剤としては、例えば
メントール、カンフルが挙げられる。薬物としては、例
えば鎮痒薬、鎮痛薬、抗炎症薬、殺菌薬が挙げられる。
抗酸化剤としては、例えばアスコルビン酸、トコフェロ
ール及びこれらの誘導体等が挙げられる。本発明の検査
材の形態は、特に限定されず、例えば、シート状、ペー
スト状が挙げられる。Examples of the keratolytic agent include lactic acid, papain, biobrase, salicylic acid, glycolic acid, citric acid and malic acid. Examples of the cooling agent include menthol and camphor. Examples of the drug include an antipruritic, an analgesic, an anti-inflammatory, and a bactericide.
Examples of the antioxidant include ascorbic acid, tocopherol and derivatives thereof. The form of the inspection material of the present invention is not particularly limited, and examples thereof include a sheet shape and a paste shape.
【0019】シート状検査材は、好ましくは、使用時に
溶媒を供給した後、ヒトの皮膚に貼付して使用する。シ
ート状検査材としては、例えば、基材と、水溶性高分子
を含有する層とを積層してなるものが挙げられる。基材
は、所定の通気性及び可撓性(柔軟性)を有するもので
ある。このような基材としては、多孔質材で構成された
ものが挙げられる。多孔質材としては、非繊維性又は繊
維性の多孔質材が挙げられる。The sheet-like test material is preferably used after being supplied with a solvent at the time of use, and then applied to human skin. Examples of the sheet-like inspection material include those obtained by laminating a base material and a layer containing a water-soluble polymer. The base material has predetermined air permeability and flexibility (flexibility). Examples of such a base material include those made of a porous material. Examples of the porous material include a non-fibrous or fibrous porous material.
【0020】非繊維性多孔質材としては、例えば、メン
ブランフィルター、発泡体(発泡ポリプロピレン、発泡
ポリエチレン、発泡ポリウレタン等)、各種多孔質フィ
ルム、メッシュ等が挙げられる。繊維性多孔質材として
は、例えば、織編物、不織布、紙類、短繊維の集合体等
が挙げられる。ここで、織編物とは、織布のような織物
や編物又はこれに類するものを含む。織物組織として
は、実用に供されている全ての種類のもの、例えば、平
織、斜文織、朱子織が使用可能である。また、編物組織
についても特に限定はなく、例えば、よこ編み(平編
み)、たて編み(トリコット編み)、丸編み、平打ち、
メリヤス編み等が挙げられる。不織布を用いる場合、繊
維の充填密度(嵩密度)等は特に限定されない。紙類と
しては、通常の紙材(洋紙、和紙)又はその積層体や、
各種合成紙を用いることができる。Examples of the non-fibrous porous material include a membrane filter, a foam (foamed polypropylene, foamed polyethylene, foamed polyurethane, etc.), various porous films, a mesh and the like. Examples of the fibrous porous material include woven and knitted fabrics, nonwoven fabrics, papers, aggregates of short fibers, and the like. Here, the woven or knitted fabric includes a woven or knitted fabric such as a woven fabric or the like. As the woven fabric, all types of practically usable ones, for example, plain weave, oblique weave, and satin weave can be used. There is also no particular limitation on the knitted structure, for example, weft knitting (flat knitting), warp knitting (tricot knitting), circular knitting, flat knitting,
Knitted knitting and the like can be mentioned. When a nonwoven fabric is used, the packing density (bulk density) of the fibers and the like are not particularly limited. As papers, ordinary paper materials (Western paper, Japanese paper) or a laminate thereof,
Various synthetic papers can be used.
【0021】このような繊維性多孔質材を構成する繊維
としては、例えば、セルロース繊維、綿、リンター、カ
ボック、亜麻、大麻、ラミー、絹、羊毛等の天然繊維、
ナイロン(ポリアミド)、テトロン、レーヨン、キュプ
ラ、アセテート、ビニロン、アクリル、ポリエチレンテ
レフタレート(ポリエステル)、ポリプロピレン等の化
学繊維、又はこれら天然及び化学繊維のうちの2以上の
組み合わせ(混紡等)を挙げることができる。The fibers constituting such a fibrous porous material include, for example, natural fibers such as cellulose fiber, cotton, linter, kabok, flax, hemp, ramie, silk, wool, etc.
Chemical fibers such as nylon (polyamide), tetron, rayon, cupra, acetate, vinylon, acrylic, polyethylene terephthalate (polyester), and polypropylene, or combinations of two or more of these natural and chemical fibers (such as blend spinning) may be mentioned. it can.
【0022】基材の厚さは、特に限定されるものではな
いが、20〜1000μmであることが好ましい。この
ような基材は、それ自体通気性を有するものであるのが
好ましい。その理由は、後述するシート状検査材を皮膚
に貼着した際に、溶媒(水分、アルコール分等)が基材
を透過して蒸発し、シート状検査材の乾燥が均一かつ良
好になされるようにするためである。The thickness of the substrate is not particularly limited, but is preferably 20 to 1000 μm. It is preferable that such a substrate itself has air permeability. The reason is that when a sheet-like test material described later is adhered to the skin, the solvent (moisture, alcohol content, etc.) passes through the base material and evaporates, and the sheet-like test material is dried uniformly and well. That's why.
【0023】水溶性高分子を含有する層(以下「水溶性
高分子層」ともいう。)を構成する組成物は、充分な水
やアルコール等の溶媒の存在下では流動性が付与され、
かつ乾燥状態では皮膜が形成され得るように調製するこ
とが好ましい。基材と、水溶性高分子を含有する層との
積層は、例えば、転写用フィルム基材に離型剤が塗布さ
れた転写用フィルムの離型剤塗布面に水溶性高分子塗布
液を塗布、乾燥し、必要により加水処理を施し、水溶性
高分子層に基材を重ね合わす方法や、基材の片面に水溶
性高分子塗布液を塗布し、乾燥する方法により行うこと
ができる。これにより、基材と水溶性高分子を含有する
層との積層体が得られる。基材が前述したような多孔質
材で構成されている場合には、水溶性高分子層の一部
が、水溶性高分子が基材の一部に含浸又は埋入した構成
であってもよい。塗布の方法としては、例えば、ロー
ル、エアナイフ、ナイフ、グラビア、マイヤーバー、フ
ァウンテンダイ等を用いたコート、スプレーコート、は
け塗り、ディッピング等いかなる方法でもよい。水溶性
高分子を含有する層の厚さは50〜400μm(乾燥
後)が好ましく、100〜300μm(乾燥後)がより
好ましい。The composition constituting the layer containing the water-soluble polymer (hereinafter also referred to as “water-soluble polymer layer”) is given fluidity in the presence of a sufficient solvent such as water or alcohol,
In addition, it is preferable to prepare so that a film can be formed in a dry state. For the lamination of the substrate and the layer containing the water-soluble polymer, for example, a water-soluble polymer coating solution is applied to the release agent-coated surface of the transfer film in which the release agent is applied to the transfer film substrate. It can be carried out by a method of drying, subjecting to a water treatment as required, and superposing the substrate on the water-soluble polymer layer, or a method of applying a water-soluble polymer coating solution on one surface of the substrate and drying. Thereby, a laminate of the substrate and the layer containing the water-soluble polymer is obtained. When the substrate is composed of a porous material as described above, a part of the water-soluble polymer layer may be configured such that the water-soluble polymer is impregnated or embedded in a part of the substrate. Good. As a method of application, any method such as coating using a roll, an air knife, a knife, gravure, a Meyer bar, a fountain die, spray coating, brushing, dipping, etc. may be used. The thickness of the layer containing the water-soluble polymer is preferably from 50 to 400 μm (after drying), and more preferably from 100 to 300 μm (after drying).
【0024】なお、転写用フィルムとしては、グラシン
紙、上質紙、コート紙、キャストコート紙などの紙基
材、これらの紙基材にポリエチレンなどの熱可塑性樹脂
をラミネートしたラミネート紙、あるいはポリエチレン
テレフタレート、ポリブチレンテレフタレート、ポリエ
チレンナフタレートなどのポリエステルフィルム、ポリ
プロピレンやポリエチレンなどのポリオレフィンフィル
ム、ポリ塩化ビニルフィルム、ポリ塩化ビニリデンフィ
ルム、ポリフッ化ビニルフィルム、ポリメチルメタクリ
レートフィルム、ポリカーボネートフィルム、エチレン
−酢酸ビニル共重合体フィルムなどのプラスチックフィ
ルムに、シリコーン樹脂、アルキッド樹脂、フッ素樹脂
などの離型剤を塗布したものなどが挙げられる。この転
写用フィルムの厚さについては特に制限はないが、通常
20〜150μm程度である。Examples of the transfer film include paper substrates such as glassine paper, woodfree paper, coated paper, and cast-coated paper; laminated paper obtained by laminating a thermoplastic resin such as polyethylene on these paper substrates; or polyethylene terephthalate. Polyester films such as polybutylene terephthalate and polyethylene naphthalate, polyolefin films such as polypropylene and polyethylene, polyvinyl chloride films, polyvinylidene chloride films, polyvinyl fluoride films, polymethyl methacrylate films, polycarbonate films, ethylene-vinyl acetate copolymer Examples thereof include those obtained by applying a release agent such as a silicone resin, an alkyd resin, or a fluororesin to a plastic film such as a united film. The thickness of the transfer film is not particularly limited, but is usually about 20 to 150 μm.
【0025】本発明の検査材は、ヒトの皮膚に適用後、
乾燥させて皮膜を形成させた後、剥離させて、顕微鏡等
による検査に供することが好ましい。顕微鏡には、観察
物の表面に光をあて反射光で観察する表面顕微鏡と観察
物の背面から光をあて透過光で観察する光透過型顕微鏡
が常用されている。After the test material of the present invention is applied to human skin,
After drying to form a film, it is preferable that the film be peeled off and subjected to an inspection using a microscope or the like. As a microscope, a surface microscope for irradiating light to the surface of an observation object and observing it with reflected light, and a light transmission microscope for irradiating light from the back of the object and observing it with transmitted light are commonly used.
【0026】表面顕微鏡による検査の場合、ルーペと同
様検査材の水溶性高分子層(虫体捕獲層)の表面を直接
観察するので、検査材は不透明であってもよい。簡便な
観察方法ではあるが、表面の凹凸が激しいと、凹部(皮
膚の凸部)は観察しにくくなるおそれがある。一方、光
透過型顕微鏡による検査に用いる場合には、水溶性高分
子層の全層が検査の対象となるが、検査材を光が透過す
る必要があるため、本発明の検査材は透明性を有するこ
とが好ましい。In the case of inspection using a surface microscope, the surface of the water-soluble polymer layer (insect-trapping layer) of the inspection material is directly observed in the same manner as a loupe, so that the inspection material may be opaque. Although this is a simple observation method, if the surface has severe irregularities, it may be difficult to observe a concave portion (a convex portion of the skin). On the other hand, when used for inspection with a light transmission microscope, all layers of the water-soluble polymer layer are to be inspected, but since the inspection material needs to transmit light, the inspection material of the present invention is transparent. It is preferable to have
【0027】このような検査材は、不織布等の基材を設
けず、更に前述した成分のうち、有色成分、例えば、酸
化チタン、タルク、無水ケイ酸、カーボンブラック等の
充填剤、その他、水溶性高分子層に非溶解性の成分を可
能な限り使用しないことにより製造することができる。Such an inspection material does not include a base material such as a nonwoven fabric, and further includes, among the components described above, colored components such as fillers such as titanium oxide, talc, silicic anhydride, carbon black, and other water-soluble materials. It can be produced by using as little insoluble components as possible in the conductive polymer layer.
【0028】また、不織布等の基材を設けない場合に
は、検査材(水溶性高分子層)の被膜強度よりも皮膚接
着力が大きいため、そのまま検査材を剥離させようとし
ても綺麗に剥離させることが困難であることから、透明
性を有する粘着シートを乾燥した水溶性高分子層(虫体
捕獲層)の上に貼り、当該粘着シートごと皮膚から剥離
させることが好ましい。When a substrate such as a non-woven fabric is not provided, the skin adhesive strength is larger than the coating strength of the test material (water-soluble polymer layer). Since it is difficult to perform this, it is preferable that a transparent pressure-sensitive adhesive sheet is stuck on the dried water-soluble polymer layer (insect capturing layer), and the pressure-sensitive adhesive sheet is peeled off from the skin.
【0029】即ち、本発明は、前記(2)又は(6)に
記載の検査材と透明性を有する粘着シートとを含む皮膚
寄生性病原体の検査材キット、並びに前記(2)又は
(6)に記載の検査材を皮膚から剥離する際に、透明性
を有する粘着シートを用いる皮膚寄生性病原体の検査方
法を提供するものでもある。That is, the present invention provides a kit for testing a skin parasitic pathogen, comprising the test material according to the above (2) or (6) and a transparent adhesive sheet, and the above (2) or (6) The present invention also provides a method for examining skin parasitic pathogens using a transparent pressure-sensitive adhesive sheet when the test material described in 1) is peeled from the skin.
【0030】前記透明性を有する粘着シートとしては、
例えば、ポリエチレンテレフタレート(PET)、ポリ
ウレタン、ポリエチレン、ポリプロピレン等の透明なシ
ート基材の一方の面に、例えばアクリル系粘着剤、ウレ
タン系粘着剤、シリコーン系粘着剤等の粘着剤を、前記
の水溶性高分子塗布液を塗布する方法と同様の方法によ
り、塗布したものが挙げられる。シート基材の厚さは、
特に制限はないが、通常20〜100μmである。粘着
剤層の厚さは、特に制限はないが、通常10〜50μm
である。Examples of the transparent pressure-sensitive adhesive sheet include:
For example, on one surface of a transparent sheet substrate such as polyethylene terephthalate (PET), polyurethane, polyethylene, or polypropylene, an adhesive such as an acrylic adhesive, a urethane-based adhesive, or a silicone-based adhesive is coated with the above-mentioned aqueous solution. What was applied by the same method as the method of applying a hydrophilic polymer coating liquid is mentioned. The thickness of the sheet substrate is
Although there is no particular limitation, it is usually 20 to 100 μm. The thickness of the pressure-sensitive adhesive layer is not particularly limited, but is usually 10 to 50 μm.
It is.
【0031】本発明の検査材の適用部位は、対象とする
皮膚寄生性病原体、例えばダニ、ノミ、シラミが高頻度
に存在する部位であることが好ましく、このうち、検査
材が適用しやすい部位であることが更に好ましい。例え
ば、対象とする窩皮膚寄生性病原体がヒト疥癬虫の場
合、本発明の検査材の適用部位として、例えば指間、
指、手掌、腕関節屈面、肘窩、腋窩の前襞、乳房、下腹
部、陰茎、陰嚢、そけい部、臍部周囲、大腿内側、臀部
等が考えられるが、検査材の適用しやすさの点で、体毛
の少ない手掌、臍部周囲、大腿内側等が好ましい。The site to which the test material of the present invention is applied is preferably a site where the target skin parasitic pathogens, for example, mites, fleas and lice, are present at high frequency. Is more preferable. For example, when the target fossa skin parasitic pathogen is a human mange, as a site to which the test material of the present invention is applied, for example, between fingers,
Fingers, palms, flexed arm joints, elbow fossa, anterior folds of the axilla, breast, lower abdomen, penis, scrotum, groin, umbilicus, medial thigh, buttocks, etc. In terms of ease, the palm, the periphery of the umbilicus, the inside of the thigh, and the like with less body hair are preferable.
【0032】また、シート状検査材の形状としては、例
えば長方形、丸形、楕円形、正方形、ハート形、ひし
形、ドーナツ形等が挙げられるが、前記の適用部位に応
じて最適な形状とすることが好ましい。以下、顕微鏡
(特に光透過型顕微鏡)による検査に適した本発明の実
施態様の一例を図1に従って説明する。Examples of the shape of the sheet-like inspection material include a rectangle, a circle, an ellipse, a square, a heart, a diamond, a donut, and the like. Is preferred. Hereinafter, an example of an embodiment of the present invention suitable for inspection with a microscope (in particular, a light transmission microscope) will be described with reference to FIG.
【0033】シート状検査材(A)は、水溶性高分子層
(虫体捕獲層)とその両面に設けられた離型シートで構
成される。離型シートとしては、前記の転写用フィルム
と同様のものが用いられる。ペースト状検査材(B)
は、前記の透明性を有する成分をエタノール、水等の溶
媒に溶解した溶液から構成される。The sheet-like inspection material (A) is composed of a water-soluble polymer layer (insect capturing layer) and release sheets provided on both sides thereof. As the release sheet, the same release sheet as described above is used. Paste inspection material (B)
Is composed of a solution in which the aforementioned transparent component is dissolved in a solvent such as ethanol or water.
【0034】シート状検査材(A)においては、離型シ
ートの一方を剥離させ、当該接着面及び/又は皮膚の適
用部分を水等に濡らし、皮膚面に貼り付け、他方の離型
シートを剥離させ、皮膚面に水溶性高分子層(虫体捕獲
層)を形成させる。ペースト状検査材(B)において
は、適量を皮膚面に塗布し、水溶性高分子層(虫体捕獲
層)を形成させる。シート状検査材(A)及びペースト
状検査材(B)とも、水溶性高分子層(虫体捕獲層)を
充分に乾燥させた後、その上に前記透明性を有する粘着
シートを貼り、当該粘着シートごと皮膚から水溶性高分
子層(虫体捕獲層)を剥離させる。In the sheet-like inspection material (A), one of the release sheets is peeled off, the adhesive surface and / or a portion to which the skin is applied is wetted with water or the like, attached to the skin surface, and the other release sheet is removed. Peel off to form a water-soluble polymer layer (insect capture layer) on the skin surface. In the paste-like test material (B), an appropriate amount is applied to the skin surface to form a water-soluble polymer layer (insect capture layer). For both the sheet-like inspection material (A) and the paste-like inspection material (B), after sufficiently drying the water-soluble polymer layer (insect capture layer), the transparent adhesive sheet is attached thereon, The water-soluble polymer layer (insect capture layer) is peeled from the skin together with the adhesive sheet.
【0035】次いで、水溶性高分子層(虫体捕獲層)を
スライドグラスに貼付し、顕微鏡検査に供する。この
際、水溶性高分子層(虫体捕獲層)を適当な溶媒、例え
ばメタノール、エタノール、水に溶解した後、スライド
グラスに貼付し、顕微鏡検査に供した方が、剥離の際に
白濁した水溶性高分子層が溶解して透明化するため、虫
体の検出が容易となるので好ましい。また、20%水酸
化カリウム水溶液等を用いると、付着した角質が溶解す
るので、更に好ましい。Next, the water-soluble polymer layer (insect capture layer) is attached to a slide glass and subjected to microscopic inspection. At this time, after dissolving the water-soluble polymer layer (insect capture layer) in an appropriate solvent, for example, methanol, ethanol, or water, the solution was stuck to a slide glass and subjected to microscopic examination, and the sample became cloudy when peeled. It is preferable because the water-soluble polymer layer dissolves and becomes transparent, thereby facilitating detection of insects. Further, it is more preferable to use a 20% aqueous solution of potassium hydroxide since the attached keratin is dissolved.
【0036】[0036]
【実施例】以下、実施例により本発明を更に具体的に説
明するが、これらの実施例は本発明の範囲を何ら制限す
るものではない。 (実施例1) シート状検査材 表1に示す各組成の水溶性高分子塗布液を調製した。EXAMPLES The present invention will be described in more detail with reference to the following Examples, which should not be construed as limiting the scope of the present invention. (Example 1) Sheet-like inspection material Water-soluble polymer coating solutions having the compositions shown in Table 1 were prepared.
【0037】[0037]
【表1】 酢酸ビニル・ビニルピロリドン共重合体 100重量部 ポリ酢酸ビニル 15重量部 スクワラン 3重量部 1,3−ブタンジオール 3重量部 無水ケイ酸 24重量部 酸化チタン 1.5重量部 エタノール 75重量部 水 37.5重量部TABLE 1 Vinyl acetate / vinyl pyrrolidone copolymer 100 parts by weight Polyvinyl acetate 15 parts by weight Squalane 3 parts by weight 1,3-butanediol 3 parts by weight Silicic anhydride 24 parts by weight Titanium oxide 1.5 parts by weight Ethanol 75 parts by weight Parts water 37.5 parts by weight
【0038】まず、酢酸ビニルとビニルピロリドン共重
合体のエタノール溶液に、酢酸ビニルの単独重合体の溶
液及び充填剤を加え、これらを撹拌した。次に、可塑剤
及び油性成分を水に溶解・分散し、前記共重合体溶液に
添加し、充分に撹拌したものを水溶性高分子塗布液とし
た。一方、基材として、ポリエステル繊維よりなる不織
布(厚さ400μm)を用意した。First, a vinyl acetate homopolymer solution and a filler were added to an ethanol solution of vinyl acetate and vinyl pyrrolidone copolymer, and these were stirred. Next, a plasticizer and an oil component were dissolved and dispersed in water, added to the copolymer solution, and sufficiently stirred to obtain a water-soluble polymer coating solution. On the other hand, a nonwoven fabric (thickness: 400 μm) made of polyester fiber was prepared as a substrate.
【0039】前記塗布液を、50μmのポリエチレンテ
レフタレートフィルムの一方の面にシリコーン樹脂から
なる離型剤を塗布した転写用フィルムの表面に塗布、乾
燥し、乾燥膜厚150μmの水溶性高分子層を形成し
た。次に、水蒸気ダンピングにより水溶性高分子層を加
水処理して軟化させ、その後、基材と水溶性高分子層を
積層し、これらをローラにて加圧し、軟化した水溶性高
分子の一部を基材中に含浸、埋入させた。基材と水溶性
高分子層との重複部分の厚さは、基材の厚さの20%程
度であった。以上のようにして、本発明のシート状検査
材を作成した。水溶性高分子層における乾燥後の溶媒含
量は5重量%であった。The coating solution was applied to the surface of a transfer film in which a release agent made of a silicone resin was applied to one surface of a 50 μm polyethylene terephthalate film, and dried to form a water-soluble polymer layer having a dry film thickness of 150 μm. Formed. Next, the water-soluble polymer layer is subjected to water treatment by steam damping to be softened and softened. Thereafter, the base material and the water-soluble polymer layer are laminated, and these are pressed by a roller, and a part of the softened water-soluble polymer is partially removed. Was impregnated and embedded in a substrate. The thickness of the overlapping portion between the substrate and the water-soluble polymer layer was about 20% of the thickness of the substrate. As described above, the sheet-like inspection material of the present invention was prepared. The solvent content of the water-soluble polymer layer after drying was 5% by weight.
【0040】(実施例2) ペースト状検査材 実施例1の水溶性高分子塗布液と同様の各組成を混合
し、ペースト状検査材を得た。溶媒(水及びエタノー
ル)の含有量は43.4重量%であった。(Example 2) Paste test material The same composition as the water-soluble polymer coating solution of Example 1 was mixed to obtain a paste test material. The content of the solvent (water and ethanol) was 43.4% by weight.
【0041】(実施例3) 透明性を有するシート状検
査材 無水ケイ酸及び酸化チタンを配合しない以外は、実施例
1と同様にして水溶性高分子塗布液を調製した。前記塗
布液を、シリコーン樹脂からなる離型剤をその表面に塗
布したポリエチレンテレフタレート製の離型シートの表
面に塗布、乾燥し、乾燥膜厚180μmの水溶性高分子
層を形成した。更に、この水溶性高分子層の表面に前記
離型シートと同様な離型シートを積層し、両面に離型シ
ートを積層した水溶性高分子層からなる透明性を有する
シート状検査材を作成した。なお、水溶性高分子層にお
ける乾燥後の溶媒含量は5重量%であった。一方、透明
なポリエチレンテレフタレートフィルム(厚さ50μ
m)の一方の面にアクリル系粘着剤(厚さ15μm)を
塗布し、透明性を有する粘着シートを作成した。Example 3 A sheet-like inspection material having transparency A water-soluble polymer coating solution was prepared in the same manner as in Example 1 except that silicic anhydride and titanium oxide were not blended. The coating liquid was applied to the surface of a release sheet made of polyethylene terephthalate having a release agent made of a silicone resin applied to the surface thereof, and dried to form a water-soluble polymer layer having a dry film thickness of 180 μm. Further, a release sheet similar to the above release sheet is laminated on the surface of the water-soluble polymer layer, and a transparent sheet-like inspection material comprising a water-soluble polymer layer in which release sheets are laminated on both sides is prepared. did. The solvent content of the water-soluble polymer layer after drying was 5% by weight. On the other hand, a transparent polyethylene terephthalate film (50 μm thick)
m) was coated with an acrylic pressure-sensitive adhesive (thickness: 15 μm) to prepare a transparent pressure-sensitive adhesive sheet.
【0042】(実施例4) 透明性を有するペースト状
検査材 無水ケイ酸及び酸化チタンを配合しない以外は、実施例
1の水溶性高分子塗布液と同様の各組成を混合し、透明
性を有するペースト状検査材を得た。溶媒(水及びエタ
ノール)の含有量は48.2重量%であった。一方、実
施例3と同様にして透明性を有する粘着シートを作成し
た。Example 4 Transparent Paste Inspection Material The same compositions as those of the water-soluble polymer coating solution of Example 1 were mixed except that silicic anhydride and titanium oxide were not added, and the transparency was measured. A paste-like inspection material was obtained. The content of the solvent (water and ethanol) was 48.2% by weight. On the other hand, a transparent pressure-sensitive adhesive sheet was prepared in the same manner as in Example 3.
【0043】(試験例)以下の各試験は、男女各5名に
対して行った。 (実施例1のシート状検査材) (1)よく洗った手の甲に墨汁を1滴たらし、均一に伸
ばして乾燥させた。 (2)実施例1のシート状検査材の水溶性高分子層(虫
体捕獲層)の表面を水で濡らし、墨汁を塗布した部分に
貼付した。 (3)約15分後、乾燥したシート状検査材を剥離し
た。 (4)皮膚に残った墨の量を観察した。 (5)剥離したシート状検査材の水溶性高分子層(虫体
捕獲層)の表面に付着した墨を表面顕微鏡(50×)で
観察した。(Test Examples) The following tests were conducted for each of five men and women. (Sheet-like inspection material of Example 1) (1) One drop of black ink was applied to the back of a well-washed hand, uniformly spread and dried. (2) The surface of the water-soluble polymer layer (insect body capturing layer) of the sheet-like inspection material of Example 1 was wetted with water and affixed to a portion where ink was applied. (3) After about 15 minutes, the dried sheet-like inspection material was peeled off. (4) The amount of black ink remaining on the skin was observed. (5) Black ink adhering to the surface of the water-soluble polymer layer (worm capturing layer) of the peeled sheet-like inspection material was observed with a surface microscope (50 ×).
【0044】(実施例2のペースト状検査材) (1)よく洗った手の甲に墨汁を1滴たらし、均一に伸
ばして乾燥させた。 (2)実施例2のペースト状検査材の皮膚に接着した面
を、墨汁を塗布した部分に薄く均一になるように塗布し
た。 (3)約20分後、乾燥し、皮膜化したペースト状検査
材を剥離した。 (4)皮膚に残った墨の量を観察した。 (5)剥離した皮膜状のペースト状検査材の皮膚へ貼り
付けた表面に付着した墨を表面顕微鏡(50×)で観察
した。(Paste-like inspection material of Example 2) (1) One drop of black ink was applied to the back of a well-washed hand, uniformly spread, and dried. (2) The surface of the paste-like inspection material of Example 2 adhered to the skin was applied to the portion where the ink was applied so as to be thin and uniform. (3) After about 20 minutes, the dried and film-formed paste-like inspection material was peeled off. (4) The amount of black ink remaining on the skin was observed. (5) The black ink adhering to the surface of the peeled film-like paste-like inspection material adhered to the skin was observed with a surface microscope (50 ×).
【0045】(実施例3の透明性を有するシート状検査
材) (1)よく洗った手の甲に墨汁を1滴たらし、均一に伸
ばして乾燥させた。 (2)実施例3の透明性を有するシート状検査材の一方
の離型シートを剥がし、露出した水溶性高分子層(虫体
捕獲層)の表面を水で濡らし、墨汁を塗布した部分に貼
付し、もう一方の離型シートを剥がした。 (3)約15分後、乾燥したシート状検査材の表面に実
施例3の透明性を有する粘着シートを貼り付けた後、シ
ート状検査材及び粘着シートごと皮膚から剥離した。 (4)皮膚に残った墨の量を観察した。 (5)剥離したシート状検査材を水で濡らし、これをス
ライドグラスに貼付した後、粘着シート側から光透過型
顕微鏡(50倍)で付着した墨を観察した。(Transparent sheet-like inspection material of Example 3) (1) One drop of black ink was applied to the back of a well-washed hand, uniformly spread, and dried. (2) Peel off one release sheet of the transparent sheet-like inspection material of Example 3, wet the surface of the exposed water-soluble polymer layer (insect capture layer) with water, and apply it to the portion where ink was applied. Then, the other release sheet was peeled off. (3) After about 15 minutes, the transparent pressure-sensitive adhesive sheet of Example 3 was attached to the surface of the dried sheet-like inspection material, and then the sheet-like inspection material and the pressure-sensitive adhesive sheet were peeled off from the skin. (4) The amount of black ink remaining on the skin was observed. (5) The peeled sheet-like inspection material was wetted with water and attached to a slide glass, and then the black ink adhered from the adhesive sheet side was observed with a light transmission microscope (50 times).
【0046】(実施例4の透明性を有するペースト状検
査材) (1)よく洗った手の甲に墨汁を1滴たらし、均一に伸
ばして乾燥させた。 (2)実施例4のペースト状検査材の皮膚に接着した面
を、墨汁を塗布した部分に薄く均一になるように塗布し
た。 (3)約20分後、乾燥し、皮膜化したペースト状検査
材の表面に実施例4の透明性を有する粘着シートを貼り
付けた後、皮膜化したペースト状検査材を粘着シートと
ともに皮膚から剥離した。 (4)皮膚に残った墨の量を観察した。 (5)剥離したペースト状検査材を水で濡らし、これを
スライドグラスに貼付した後、粘着シート側から光透過
型顕微鏡(50倍)で付着した墨を観察した。(Transparent paste-like inspection material of Example 4) (1) One drop of black ink was applied to the back of a well-washed hand, uniformly spread and dried. (2) The surface of the paste-like test material of Example 4 adhered to the skin was thinly and uniformly applied to the portion where the ink was applied. (3) After about 20 minutes, the transparent pressure-sensitive adhesive sheet of Example 4 was attached to the surface of the dried and film-formed paste-like test material, and the film-formed paste-like test material was removed from the skin together with the pressure-sensitive adhesive sheet. Peeled off. (4) The amount of black ink remaining on the skin was observed. (5) The peeled paste-like test material was wetted with water and attached to a slide glass, and then the black ink adhered from the adhesive sheet side was observed with a light transmission microscope (50 times).
【0047】(比較例:一般粘着シート)シート状検査
材の代わりに、25μmの延伸ポリプロピレンフィルム
上にアクリル粘着剤を展延塗布した一般粘着シートを貼
付した以外は実施例1のシート状検査材と同様の手順で
試験を行った。(Comparative Example: General adhesive sheet) The sheet-like inspection material of Example 1 except that instead of the sheet-like inspection material, a general adhesive sheet in which an acrylic adhesive was spread and applied on a 25 μm stretched polypropylene film was applied. A test was performed in the same procedure as described above.
【0048】(1)皮膚に残った墨の量の観察結果 評価基準を以下に示す。 1 ほとんど取れていない 2 表面は取れているが、毛穴・皮溝中のものは全く取
れていない 3 毛穴・皮溝中のものも多少は取れている 4 ほぼ取れている 5 完全に取れている 結果を表2に示す。(1) Observation results of the amount of black ink remaining on the skin Evaluation criteria are as follows. 1 Almost not removed 2 Surface is removed but nothing in pores / skins is removed 3 Some in pores / skins is also removed 4 Almost removed 5 Completely removed Table 2 shows the results.
【0049】[0049]
【表2】 [Table 2]
【0050】表2から明らかなように、実施例1ないし
4の検査材は、いずれも比較例の一般粘着シートに比べ
て毛穴・皮溝中の墨を除去できていた。また、取れ方に
男女の差はなかった。As is clear from Table 2, all of the test materials of Examples 1 to 4 were able to remove black ink in pores and skin grooves as compared with the general adhesive sheet of Comparative Example. In addition, there was no difference between men and women in how to take.
【0051】(2)表面顕微鏡による墨の観察結果 実施例1及び2とも検査材の表面に墨が付着しており、
皮膚から墨の粒子を捕獲していることが確認された。 (3)光透過型顕微鏡による墨の観察結果 実施例3及び4とも皮膚の角質等の影響を受けずに鮮明
に墨の粒子(凝集物)が確認できた。(2) Results of Observation of Black Using a Surface Microscope In both Examples 1 and 2, black was adhered to the surface of the test material.
It was confirmed that black ink particles were captured from the skin. (3) Observation of black ink by light transmission microscope In both Examples 3 and 4, black particles (aggregates) could be clearly confirmed without being affected by skin keratin and the like.
【0052】[0052]
【発明の効果】本発明の検査材によれば、毛穴等を含む
皮膚表面に棲息するヒト疥癬虫をはじめとする皮膚寄生
性病原体を確実に捕獲し、検出率を飛躍的に向上させる
ことができる。According to the test material of the present invention, skin parasitic pathogens such as human scabies living on the skin surface including pores and the like can be reliably captured, and the detection rate can be dramatically improved. .
【図1】顕微鏡による検査に適した本発明の実施態様の
一例を説明するための図である。FIG. 1 is a diagram for explaining an example of an embodiment of the present invention suitable for inspection with a microscope.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) G01N 33/50 G01N 33/50 Q 33/569 33/569 A ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) G01N 33/50 G01N 33/50 Q 33/569 33/569 A
Claims (8)
体の検査材。1. A test material for skin parasitic pathogens containing a water-soluble polymer.
査材。3. The inspection material according to claim 1, which is in the form of a sheet.
を含有する層とを積層してなる請求項1記載の検査材。4. The inspection material according to claim 1, which is in the form of a sheet and is formed by laminating a substrate and a layer containing a water-soluble polymer.
4記載の検査材。5. The inspection material according to claim 4, wherein the substrate has air permeability and flexibility.
検査材。6. The inspection material according to claim 1, which is in the form of a paste.
有する粘着シートとを含む皮膚寄生性病原体の検査材キ
ット。7. A test material kit for skin parasitic pathogens, comprising the test material according to claim 2 and a transparent adhesive sheet.
剥離する際に、透明性を有する粘着シートを用いる皮膚
寄生性病原体の検査方法。8. A method for examining skin parasitic pathogens using a transparent adhesive sheet when peeling the test material according to claim 2 or 6 from the skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001058735A JP2002098687A (en) | 2000-07-18 | 2001-03-02 | Inspection agent for dermatropic pathogen |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000217465 | 2000-07-18 | ||
JP2000-217465 | 2000-07-18 | ||
JP2001058735A JP2002098687A (en) | 2000-07-18 | 2001-03-02 | Inspection agent for dermatropic pathogen |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002098687A true JP2002098687A (en) | 2002-04-05 |
Family
ID=26596236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001058735A Pending JP2002098687A (en) | 2000-07-18 | 2001-03-02 | Inspection agent for dermatropic pathogen |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2002098687A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109642856A (en) * | 2016-08-31 | 2019-04-16 | 株式会社益力多本社 | The preparation method of skin analysis or observation sample product |
CN112674940A (en) * | 2018-05-21 | 2021-04-20 | 美利肯公司 | Wound care device with fluid transfer and adhesive properties |
KR20220069368A (en) * | 2020-11-20 | 2022-05-27 | 대한민국(질병관리청장) | Methods for investigating pathogen infection of Micro insect |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11349440A (en) * | 1998-06-10 | 1999-12-21 | Lintec Corp | Keratinous plug-removing sheet and its production |
JPH11349432A (en) * | 1998-06-10 | 1999-12-21 | Lintec Corp | Agent for removing cornoid lamella and sheet for removing cornoid lamella |
-
2001
- 2001-03-02 JP JP2001058735A patent/JP2002098687A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11349440A (en) * | 1998-06-10 | 1999-12-21 | Lintec Corp | Keratinous plug-removing sheet and its production |
JPH11349432A (en) * | 1998-06-10 | 1999-12-21 | Lintec Corp | Agent for removing cornoid lamella and sheet for removing cornoid lamella |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109642856A (en) * | 2016-08-31 | 2019-04-16 | 株式会社益力多本社 | The preparation method of skin analysis or observation sample product |
CN109642856B (en) * | 2016-08-31 | 2022-10-14 | 株式会社益力多本社 | Method for preparing sample for skin analysis or observation |
CN112674940A (en) * | 2018-05-21 | 2021-04-20 | 美利肯公司 | Wound care device with fluid transfer and adhesive properties |
KR20220069368A (en) * | 2020-11-20 | 2022-05-27 | 대한민국(질병관리청장) | Methods for investigating pathogen infection of Micro insect |
KR102475352B1 (en) * | 2020-11-20 | 2022-12-08 | 대한민국 | Methods for investigating pathogen infection of Micro insect |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11229583B2 (en) | Multilayer nanofiber sheet and adhesion method for same | |
JP2935343B2 (en) | Sheet pack | |
US6506394B1 (en) | Delivery of a botanical extract to a treated substrate for transfer to skin | |
RU2751639C2 (en) | Method for providing beneficial impact on skin | |
US20130122069A1 (en) | Nanofiber laminate sheet | |
AU2006276792A1 (en) | Appliance for delivering a composition | |
CN111698984A (en) | Method of making a barrier patch with a dissolvable film | |
JP6315659B2 (en) | Nanofiber laminated sheet | |
JP2011132633A (en) | Nanofiber sheet | |
JP3494334B2 (en) | Sheet pack | |
JP2002098687A (en) | Inspection agent for dermatropic pathogen | |
JP2017114030A (en) | Laminate sheet having water-soluble nanofiber layer | |
JP7296292B2 (en) | nanofiber sheet | |
WO2020241685A1 (en) | Nanomesh multilayer body, method for producing conductive circuit and nanomesh bonding kit | |
JP2009091371A (en) | Method of application of wrinkle-stretch bonding sheet, and wrinkle-stretch bonding sheet | |
KR20090058294A (en) | Compositions and methods for making adhesive cosmetic patches with skin-protective sponges | |
JPH10245319A (en) | Composition for pack cosmetic | |
WO2021161251A1 (en) | Cosmetic product | |
JPH07330575A (en) | Sheet-like pack | |
JPH11199435A (en) | Pack cosmetic | |
US20140220101A1 (en) | Substantially dry nicotinamide pads for treatment of skin inflammation | |
JP2004261440A (en) | Wet tissue | |
JP2004316017A (en) | Fiber structure | |
KR20180107991A (en) | Nanofiber Mask sheet composed of soluble and insoluble polymers | |
TWI837420B (en) | Functional sheets, absorbent articles containing the functional sheets, and methods of manufacturing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071119 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20091118 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091201 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100406 |